Not the VC, but rather....
1. I assume this was from this year, and not last? Your post said 2013. If it WAS from last year, then.....
2. I find it odd that someone would shy away from something so remarkable, just because the stock is so affordable. If I could buy more shares of Benitec, I would. And at 1.2 cents, I would have been a millionaire today if I would have known about Benitec back then. And BNIKF is still awaiting its full potential. I can't wait until I see the results of this year's results. I may not be a millionaire investor at the moment, but I can read and have a basic level of understanding to know when something is worth investing in. I certainly did my homework when investing in Benitec. I had about 100 or so shares of Gilead. Sure it's gone up 100%, but Potential is not as great as with Benitec. So I sold out of Gilead when it was 72.00 bucks. But if TT-034 truly has pangenotypic applications in one shot, that can cure 100% of the time, with no sides. You basically have THE answer for Hep C. And THAT my friends, is ginormous.
Market Data 
Markets 
AI
